Island Pharmaceuticals Limited (ASX:ILA)
Australia · Delayed Price · Currency is AUD 0.4150
+0.0400 (10.67%)
Jan 30, 2026, 2:27 PM AEST
Island Pharmaceuticals Market Cap
Island Pharmaceuticals has a market cap or net worth of 100.89 million as of January 29, 2026. Its market cap has increased by 226.82% in one year.
Market Cap
100.89M
Enterprise Value
93.64M
Revenue
118.91K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.42
Market Cap Chart
Since April 13, 2021, Island Pharmaceuticals's market cap has increased from 42.51M to 100.89M, an increase of 137.35%. That is a compound annual growth rate of 19.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 100.89M | -12.79% |
| Dec 31, 2025 | 115.69M | 274.76% |
| Dec 31, 2024 | 30.87M | 299.86% |
| Dec 29, 2023 | 7.72M | -48.65% |
| Dec 28, 2022 | 15.03M | -27.45% |
| Dec 31, 2021 | 20.72M | -51.25% |
| Apr 13, 2021 | 42.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Starpharma Holdings | 142.77M |
| Arovella Therapeutics | 108.11M |
| Imugene | 102.33M |
| Proteomics International Laboratories | 100.72M |
| LTR Pharma | 99.95M |
| Alterity Therapeutics | 87.00M |
| EZZ Life Science Holdings | 86.32M |
| Cynata Therapeutics | 83.41M |